ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
Dow Jones
37.815,92
-1,49%
Euro vs US Dollar
1,0669
-0,44%
Bitcoin
60.123,63
-5,82%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Mind Medicine MindMed Inc (MNMD)

  7. Mind Medicine MindMed Inc (MNMD) News

MNMD Mind Medicine MindMed Inc

9,573
0,543 (6,01%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:33:31
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Mind Medicine MindMed Inc MNMD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,543 6,01% 9,573 23:33:31
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
9,01 8,81 9,55 9,52 9,03
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202413:00BWMindMed to Present at Upcoming May Medical Conferences
02.4.202413:00BWMindMed to Present at Upcoming April Medical Conferences
01.4.202423:00BWMindMed Announces Voluntary Delisting from Cboe Canada
11.3.202413:32EDGAR2Form 8-K - Current report
11.3.202412:00BWMindMed to Participate in the Leerink Partners 2024 Global..
07.3.202414:19EDGAR2Form 8-K - Current report
07.3.202413:13BWMind Medicine (MindMed) Inc. Announces Pricing of..
07.3.202413:09EDGAR2Form S-3MEF - Registration adding securities to prior Form..
07.3.202412:56EDGAR2Form 8-K - Current report
07.3.202412:00BWMindMed Receives FDA Breakthrough Therapy Designation and..
01.3.202419:56EDGAR2Form 144 - Report of proposed sale of securities
01.3.202415:00BWMindMed to Host Conference Call and Webcast to Discuss Data..
29.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202413:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28.2.202413:15EDGAR2Form 8-K - Current report
28.2.202413:05BWMindMed Reports 2023 Financial Results and Business Updates
22.2.202413:00BWMindMed to Host Conference Call and Webcast to Discuss 2023..
07.2.202413:00BWMindMed to Participate in the 34th Annual Oppenheimer..
08.1.202414:00EDGAR2Form 8-K - Current report
08.1.202413:45BWMindMed Announces Business Update and Anticipated Milestones..
26.12.202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202322:24EDGAR2Form 144 - Report of proposed sale of securities
14.12.202313:57EDGAR2Form 8-K - Current report
14.12.202313:30BWMindMed Announces Positive Topline Results from Phase 2b..
02.11.202321:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:15EDGAR2Form 8-K - Current report
02.11.202321:01BWMindMed Reports Third Quarter 2023 Financial Results and..
26.10.202313:30BWMindMed to Host Conference Call and Webcast to Discuss Third..
24.10.202313:30BWMindMed Completes Enrollment of Phase 2a Trial of MM-120 in..
03.10.202313:30BWMindMed to Present Data on the Preclinical Activity of..
26.9.202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.9.202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.9.202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.9.202303:02EDGAR2Form 144 - Report of proposed sale of securities
26.9.202303:01EDGAR2Form 144 - Report of proposed sale of securities
26.9.202303:01EDGAR2Form 144 - Report of proposed sale of securities
15.9.202323:27EDGAR2Form 8-K/A - Current report: [Amend]
15.9.202323:23EDGAR2Form 8-K/A - Current report: [Amend]
14.9.202313:30BWMindMed to Participate in the TD Cowen 3rd Annual Novel..
12.9.202313:30BWMindMed Completes Enrollment of Phase 2b Trial of MM-120 in..
29.8.202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.8.202316:35EDGAR2Form 144 - Report of proposed sale of securities
28.8.202315:16EDGAR2Form 144 - Report of proposed sale of securities
28.8.202313:30BWMindMed to Participate at September Investor Conferences
14.8.202314:31EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
MNMD
Mind Medicine MindMed
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten